H19 and neoplasm: Furthermore, subcutaneous injection of organoids with H19 knockdown (OWCM-155-shH19) in mice demonstrated significantly slower growth with reduced tumor weight and volume as compared to mice injected with control (OWCM-155-shSCR) organoids (Fig. 4D, E, Supplementary Fig. 10C).